Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital
Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcinoma patients undergoing gastrectomy. The secondary endpoints, including the physical activity, weight loss, and nutritional profiles, will be evaluated among these patients.
adult gastric cancer receiving gastrectomy
Hepatic insufficiency
Renal insufficiency
can not tolerate oral or enteral feeding 7 days after gastrectomy
can not receive computed tomograph